Clinical Trials Directory

Trials / Conditions / Metastatic Endometrial Cancer

Metastatic Endometrial Cancer

8 registered clinical trials studyying Metastatic Endometrial Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
NCT06533332
EtiraRx Australia Pty LtdPhase 1
RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NCT06586957
NiKang Therapeutics, Inc.Phase 1
CompletedEfficacy Assessment of Lenvatinib Associated with Pembrolizumab in Metastatic Endometrial Cancer: a French Mul
NCT06599463
ARCAGY/ GINECO GROUP—
TerminatedA Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
NCT06264921
NiKang Therapeutics, Inc.Phase 1
TerminatedTislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
NCT04906382
Floor Backes, MDEARLY_Phase 1
CompletedRucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
NCT03617679
University of Colorado, DenverPhase 2
TerminatedDurvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
NCT03277482
Dana-Farber Cancer InstitutePhase 1
Active Not RecruitingAvelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelum
NCT02912572
Dana-Farber Cancer InstitutePhase 2